TickerFacts.

NeoGenomics Inc (NEO): R&D Expense

Annual figures by period end, from SEC filings.

$37.08M
Year ended 2025-12-31
$38.17M
Trailing 12 months to 2026-06-30
+6.9%
3-year compound annual growth
+35.1%
5-year compound annual growth
+24.3%
10-year compound annual growth
2011-12-31: $543.0K2012-12-31: $2.28M2013-12-31: $2.44M2014-12-31: $2.69M2015-12-31: $4.20M2016-12-31: $4.65M2017-12-31: $3.64M2018-12-31: $3.00M2019-12-31: $8.49M2020-12-31: $8.23M2021-12-31: $21.87M2022-12-31: $30.33M2023-12-31: $27.31M2024-12-31: $31.16M2025-12-31: $37.08M$37.08M
2011-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$37.08M+19.0%2026-02-17, From 2025-01-01
2024-12-31$31.16M+14.1%2026-02-17, From 2024-01-01
2023-12-31$27.31M-9.9%2026-02-17, From 2023-01-01
2022-12-31$30.33M+38.6%2025-02-18, From 2022-01-01
2021-12-31$21.87M+165.8%2024-02-20, From 2021-01-01
2020-12-31$8.23M-3.0%2023-02-24, From 2020-01-01
2019-12-31$8.49M+182.8%2022-02-25, From 2019-01-01
2018-12-31$3.00M-17.5%2021-02-25, From 2018-01-01
2017-12-31$3.64M-21.8%2020-02-28, From 2017-01-01
2016-12-31$4.65M+10.7%2019-02-26, From 2016-01-01
2015-12-31$4.20M+56.1%2018-03-13, From 2015-01-01
2014-12-31$2.69M+10.2%2017-03-14, From 2014-01-01
2013-12-31$2.44M+7.0%2016-04-18, From 2013-01-01
2012-12-31$2.28M+320.1%2015-03-03, From 2012-01-01
2011-12-31$543.0Kn/a2014-02-24, From 2011-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
NeoGenomics Inc (NEO)2025-12-31$37.08M+19.0%
20/20 Biolabs, Inc. (AIDX)2025-12-31$592.6K-53.0%

Compare NEO, AIDX side by side · Screen every company in Services-Testing Laboratories ↗